This company has been acquired
OptiNose Future Growth
Future criteria checks 5/6
OptiNose is forecast to grow earnings and revenue by 56.3% and 21.3% per annum respectively while EPS is expected to grow by 57.2% per annum.
Key information
56.3%
Earnings growth rate
57.23%
EPS growth rate
| Pharmaceuticals earnings growth | 14.6% |
| Revenue growth rate | 21.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 19 May 2025 |
Recent future growth updates
Recent updates
Improved Prescription Fulfillment And Primary Care Entry Will Unlock Opportunity
Enhanced sales force execution and improved prescription fulfillment processes are expected to drive revenue growth through better market penetration.Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce
The OptiNose, Inc. ( NASDAQ:OPTN ) share price has done very well over the last month, posting an excellent gain of...OptiNose, Inc. (NASDAQ:OPTN) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
To the annoyance of some shareholders, OptiNose, Inc. ( NASDAQ:OPTN ) shares are down a considerable 29% in the last...OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 31%
Unfortunately for some shareholders, the OptiNose, Inc. ( NASDAQ:OPTN ) share price has dived 31% in the last thirty...Earnings Release: Here's Why Analysts Cut Their OptiNose, Inc. (NASDAQ:OPTN) Price Target To US$3.50
One of the biggest stories of last week was how OptiNose, Inc. ( NASDAQ:OPTN ) shares plunged 42% in the week since its...Slammed 34% OptiNose, Inc. (NASDAQ:OPTN) Screens Well Here But There Might Be A Catch
OptiNose, Inc. ( NASDAQ:OPTN ) shareholders that were waiting for something to happen have been dealt a blow with a 34...Market Cool On OptiNose, Inc.'s (NASDAQ:OPTN) Revenues Pushing Shares 30% Lower
OptiNose, Inc. ( NASDAQ:OPTN ) shareholders won't be pleased to see that the share price has had a very rough month...Not Many Are Piling Into OptiNose, Inc. (NASDAQ:OPTN) Stock Yet As It Plummets 42%
The OptiNose, Inc. ( NASDAQ:OPTN ) share price has fared very poorly over the last month, falling by a substantial 42...There's Reason For Concern Over OptiNose, Inc.'s (NASDAQ:OPTN) Massive 32% Price Jump
OptiNose, Inc. ( NASDAQ:OPTN ) shares have continued their recent momentum with a 32% gain in the last month alone. But...Revenues Working Against OptiNose, Inc.'s (NASDAQ:OPTN) Share Price
You may think that with a price-to-sales (or "P/S") ratio of 2.1x OptiNose, Inc. ( NASDAQ:OPTN ) is a stock worth...OptiNose, Inc. (NASDAQ:OPTN) Might Not Be As Mispriced As It Looks After Plunging 29%
OptiNose, Inc. ( NASDAQ:OPTN ) shareholders won't be pleased to see that the share price has had a very rough month...The Consensus EPS Estimates For OptiNose, Inc. (NASDAQ:OPTN) Just Fell Dramatically
The latest analyst coverage could presage a bad day for OptiNose, Inc. ( NASDAQ:OPTN ), with the analysts making...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 137 | 2 | -5 | 42 | 2 |
| 12/31/2026 | 114 | -12 | -19 | 25 | 2 |
| 12/31/2025 | 81 | -57 | -30 | -1 | 1 |
| 3/31/2025 | 82 | -30 | -34 | -34 | N/A |
| 12/31/2024 | 78 | -22 | -45 | -45 | N/A |
| 9/30/2024 | 76 | -31 | -40 | -40 | N/A |
| 6/30/2024 | 75 | -41 | -36 | -35 | N/A |
| 3/31/2024 | 74 | -31 | -32 | -32 | N/A |
| 12/31/2023 | 71 | -35 | -21 | -21 | N/A |
| 9/30/2023 | 72 | -41 | -45 | -45 | N/A |
| 6/30/2023 | 72 | -46 | -58 | -58 | N/A |
| 3/31/2023 | 73 | -68 | -59 | -59 | N/A |
| 12/31/2022 | 76 | -75 | -68 | -68 | N/A |
| 9/30/2022 | 78 | -75 | -67 | -67 | N/A |
| 6/30/2022 | 80 | -77 | -59 | -59 | N/A |
| 3/31/2022 | 77 | -82 | -68 | -68 | N/A |
| 12/31/2021 | 75 | -82 | -77 | -77 | N/A |
| 9/30/2021 | 68 | -91 | -80 | -79 | N/A |
| 6/30/2021 | 62 | -95 | -86 | -85 | N/A |
| 3/31/2021 | 54 | -97 | -87 | -86 | N/A |
| 12/31/2020 | 49 | -100 | -87 | -86 | N/A |
| 9/30/2020 | 44 | -101 | -86 | -85 | N/A |
| 6/30/2020 | 41 | -109 | -85 | -85 | N/A |
| 3/31/2020 | 37 | -110 | -90 | -89 | N/A |
| 12/31/2019 | 35 | -110 | -91 | -91 | N/A |
| 9/30/2019 | 27 | -111 | -94 | -93 | N/A |
| 6/30/2019 | 16 | -108 | -103 | -102 | N/A |
| 3/31/2019 | 11 | -105 | -100 | -99 | N/A |
| 12/31/2018 | 7 | -107 | N/A | -92 | N/A |
| 9/30/2018 | 4 | -101 | N/A | -85 | N/A |
| 6/30/2018 | 2 | -93 | N/A | -70 | N/A |
| 3/31/2018 | 1 | -81 | N/A | -51 | N/A |
| 12/31/2017 | N/A | -62 | N/A | -36 | N/A |
| 9/30/2017 | N/A | -43 | N/A | -28 | N/A |
| 6/30/2017 | N/A | -35 | N/A | -24 | N/A |
| 3/31/2017 | N/A | -46 | N/A | -24 | N/A |
| 12/31/2016 | 48 | 2 | N/A | 22 | N/A |
| 12/31/2015 | 0 | -40 | N/A | -29 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OPTN is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).
Earnings vs Market: OPTN is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: OPTN is expected to become profitable in the next 3 years.
Revenue vs Market: OPTN's revenue (21.3% per year) is forecast to grow faster than the US market (8.5% per year).
High Growth Revenue: OPTN's revenue (21.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OPTN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 18:29 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
OptiNose, Inc. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gary Nachman | BMO Capital Markets Equity Research |
| Glen Santangelo | Jefferies LLC |
| David Steinberg | Jefferies LLC |